News & Events
Stay update
European Cancer Congress 2013 (ECCO-ESMO-ESTRO) ▾
European Cancer Congress 2013 (ECCO-ESMO-ESTRO)
Location: Amsterdam (The Netherlands)
MolMed at this event: Delivering updates on clinical trials of NGR-hTNF
Location: Amsterdam (The Netherlands)
MolMed at this event: Delivering updates on clinical trials of NGR-hTNF
Location: McCormick Place, Chicago (IL, USA)
MolMed at this event: oral and poster presentations of TK and NGR-hTNF clinical development updates
Location: McCormick Place, Chicago (IL, USA)
MolMed at this event: Exhibitor in Booth 4217 - Hall C - Italy Pavilion
Location: Barcelona (Spain)
MolMed at this event: Company presentation on Tuesday 12 March at 10:15 AM (room 119, first floor) within the "Cancer" track
Location: Hamburg, Germany
MolMed at this event: Company presentation on November, 13 2012 at 09:30 AM in Room B2 on level 1
Location: Versailles
Location: Yokohama
Location: Vienna, Austria
MolMed at this event: Update on clinical development of NGR-hTNF
Location: Boston
MolMed at this event: Company presentation at 10:00 AM in Red Socks Room 104 A
Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.